NCT06314672 · Ohio State University Comprehensive Cancer Center
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
What this study is about
This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical trial referrals and enrollment in racial/ethnic minorities. Progress in cancer prevention, detection and treatment can only be made by identifying and validating new and improved methods, compounds and modalities in clinical trials.
View original scientific description
This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical trial referrals and enrollment in racial/ethnic minorities. Progress in cancer prevention, detection and treatment can only be made by identifying and validating new and improved methods, compounds and modalities in clinical trials. Unfortunately, participation in clinical trials is not equal across all racial and ethnic groups, limiting progress against cancer in all population groups and further widening the disparity gap. To change this picture, concerted effort needs to be directed both at the communities at risk for being left out of trials and the systems that cause the disparities at all levels involved in accrual to clinical trials. The CUSP2CT project may have the potential to increase referral and accrual of racial/ethnic minorities to prevention/control and treatment trials.
Interventions
PROCEDURE
Accrual
Participate in AEP
PROCEDURE
Discussion
Participate in implementation discussions
OTHER
Educational Activity
Participate in educational sessions/activities
OTHER
Interview
Undergo interview
OTHER
Review
Undergo data capture review
OTHER
Survey Administration
Ancillary studies
Primary outcome measures
Change in referral rate to clinical trials (CTs) (short-term outcomes)
Time frame: Baseline to 24 months
Calculate change in clinical trial referrals
Change in accrual of minorities to CTs (short-term outcomes)
Time frame: Baseline to 24 months
Calculate the change in clinical trial minority enrollments
CT accrual and retention due to patient navigation (short-term outcomes)
Time frame: Baseline to 24 months
Calculate accrual and retention rates
Identification of program gaps in trial accrual (long-term outcomes)
Time frame: Up to 24 months
Define gaps in trial accrual
Uptake of program in other clinics (long-germ outcomes)
Time frame: Up to 24 months
Calculate the number of clinics who adapt program
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Phase I: 9 counties in the OSUCCC catchment area
- Phase II: Patients, providers, and hospital systems/referral centers that directly addresses challenges identified in Phase I
- Phase II: The project will involve the OSUCCC, the OSU James Cancer Network sites and the Columbus and Dayton NCORP sites
Where
- Columbus, Ohio
Collaborators
National Cancer Institute (NCI)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jun 9, 2026 · Source of record for eligibility and locations